[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-434001-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-434001-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","medication-related-osteonecrosis-of-the-jaw-an-evidence-based-2025-position-statement-from-a-korean-multidisciplinary-task-force","Medication-Related Osteonecrosis of the Jaw - An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force","","Medication-related osteonecrosis of the jaw (MRONJ) has become a growing clinical challenge worldwide due to population aging and increasing use of antiresorptive agents. To provide tailored clinical guidance, a Korean multidisciplinary task force convened to develop an evidence-based 2025 position statement. The manuscript documents the background, rationale, and collaborative framework supporting the recommended approach, aiming to inform clinical decision-making and standardize patient management strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/medication-related-osteonecrosis-of-the-jaw-an-evidence-based-2025-position-statement-from-a-korean-multidisciplinary-task-force/434001/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/medication-related-osteonecrosis-of-the-jaw-an-evidence-based-2025-position-statement-from-a-korean-multidisciplinary-task-force/434001.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-29",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is medication-related osteonecrosis of the jaw (MRONJ) a growing problem?","Question",{"text":63,"@type":64},"MRONJ is increasingly reported worldwide alongside population aging and more frequent use of antiresorptive agents.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the purpose of the 2025 position statement?",{"text":68,"@type":64},"It provides tailored, evidence-based clinical guidance to support standardized decision-making for MRONJ.",{"name":70,"@type":61,"acceptedAnswer":71},"Who developed the recommendations?",{"text":72,"@type":64},"The document is developed by a Korean multidisciplinary task force representing multiple clinical and research groups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},434001,1790740544,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":99,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Special Article  \nEndocrinol Metab 2025;40:787-810 [https://doi.org/10.3803/EnM.2025.2712](https://doi.org/10.3803/EnM.2025.2712)[ ](https://doi.org/10.3803/EnM.2025.2712)[pISSN 2093-596X](pISSN 2093-596X) · eISSN 2093-5978  \nMedication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force  \nJin-Woo Kim1, Sung-Hye Kong2, Jae-Young Kim3, Mi Kyung Kwak4, Jun-Young Kim5, Ji-Hyeon Oh6,  \nHyung-Youl Park7, BeomTaek Kim8, Young-Kyun Lee9, Jeong Joon Han 10, Moon-Young Kim11, Yong Jun Choi12, Yong-Dae Kwon 13, Kwang-Sup Song 14, Beom-Jun Kim15, Sun-Jong Kim 1, Seung-Hoon Baek16, Dong Ock Lee17, Han Seok Choi 18, Ha Young Kim19, Tae-Geon Kwon20  \n1Department of Oral and Maxillofacial Surgery, Ewha Womans University College of Medicine, Seoul; 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam; 3Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital, Yonsei University College of Dentistry, Seoul; 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong; 5Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, Seoul; 6Department of Oral and MaxilloFacial Surgery, Dental Hospital, Gangneung-Wonju National University, Gangneung; 7Department of Orthopedic Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul; 8Department of Family Practice & Community Health, Ajou University School of Medicine and Graduate School of Medicine, Suwon; 9Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam; 10Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul; 11Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Cheonan; 12Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon; 13Department of Oral and Maxillofacial Surgery, Kyung Hee University College of Dentistry; 14Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine; 15Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical  \n\n| Received: 3 October 2025, Revised: 11 November 2025, Accepted: 17 November 2025\u003Cbr>Corresponding authors: Jin-Woo Kim\u003Cbr>Department of Oral and Maxillofacial Surgery, Ewha Womans University College of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea\u003Cbr>Tel: +82-2-2650-2720, Fax: +82-2-2650-2754, E-mail:[jwkim84@ewha.ac.kr](jwkim84@ewha.ac.kr)\u003Cbr>Dong Ock Lee\u003Cbr>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea\u003Cbr>Tel: +82-10-3737-3436, Fax: +82-31-920-1238, [E-mail:](E-mail: dolee@ncc.re.kr)[ dolee@ncc.re.kr](E-mail: dolee@ncc.re.kr)\u003Cbr>Han Seok Choi\u003Cbr>Division of Endocrinology and Metabolism, Department of Internal Medicine, Dongguk University Ilsan Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326, Korea\u003Cbr>Tel: +82-31-961-5777, Fax: +82-31-961-8369, [E-mail:](E-mail: hschoi402@dumc.or.kr)[ hschoi402@dumc.or.kr](E-mail: hschoi402@dumc.or.kr)\u003Cbr>Ha Young Kim\u003Cbr>Division of Endocrinology, Department of Internal Medicine, GangneungAsan Hospital, University of Ulsan College of Medicine, 38 Bangdong-gil, Gangneung 25440, Korea\u003Cbr>Tel: +82-33-610-4580, Fax: +82-33-641-8310, [E-mail:](E-mail: hykimmd@hanmail.net)[ hykimmd@hanmail.net](E-mail: hykimmd@hanmail.net) | Tae-Geon Kwon\u003Cbr>Department of Oral & Maxillofacial Surgery, School of Dentistry, Kyungpook National University, 2175 Dalgubeol-daero, Jung-gu, Daegu 41940, Korea Tel: +82-53-600-7574, Fax: +82-53-426-5365, [E-mail:](E-mail: kwondk@knu.ac.kr)[ kwondk@knu.ac.kr](E-mail: kwondk@knu.ac.kr)\u003Cbr>This manuscript is","cbCaiuQ9wiLbzVGc","https://ap.wps.com/l/cbCaiuQ9wiLbzVGc","pdf",500626,24,"English","# Background\n# Rationale for an Evidence-Based Position Statement\n# Multidisciplinary Task Force Approach\n# Intended Clinical Guidance","[{\"question\":\"Why is medication-related osteonecrosis of the jaw (MRONJ) a growing problem?\",\"answer\":\"MRONJ is increasingly reported worldwide alongside population aging and more frequent use of antiresorptive agents.\"},{\"question\":\"What is the purpose of the 2025 position statement?\",\"answer\":\"It provides tailored, evidence-based clinical guidance to support standardized decision-making for MRONJ.\"},{\"question\":\"Who developed the recommendations?\",\"answer\":\"The document is developed by a Korean multidisciplinary task force representing multiple clinical and research groups.\"}]","Medication-Related Osteonecrosis of the Jaw - An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force | PDF",1790666522]